My work has focused (a) the contribution of personality, psychiatric conditions, and emotional processes to the causes and treatment of alcohol and tobacco addiction, (b) methods for assessing alcohol use, problems, and dependence, and (c) the etiology and treatment of the co-use of alcohol and tobacco. My most recent research examines the application of positive psychotherapy to smoking cessation and a brief alcohol intervention for HIV-infected heavy drinking men who have sex with men.

Biography

Brief Bio

Christopher W. Kahler, PhD-Professor (Research)
Dr. Kahler is Professor and Chair of the Department of Behavioral and Social Sciences in the Public Health Program at the Warren Alpert Medical School of Brown University. He received his Ph.D. in 1998 from Rutgers University and joined the Brown Medical School faculty that year. He is currently the Director of Biostatistics at the Center for Alcohol and Addiction Studies. Dr. Kahler's work focuses on (a) the role of personality and emotion in heavy alcohol use and smoking, (b) the etiology and treatment of combined heavy drinking and smoking, and (c) the role of alcohol in the treatment of HIV infection. He is currently the Principal Investigator on an NIAAA-funded laboratory study on alcohol administration and smoking relapse risk, an NIAAA-funded randomized clinical trial of naltrexone for at-risk and problem drinkers seeking smoking cessation treatment, and an NCI-funded treatment development project to adapt Positive Psychotherapy for use in smoking cessation treatment with low positive affect smokers. He is also the Scientific Director of the NIAAA-funded Alcohol Research Center on HIV (ARCH) and is PI of a major research component evaluating a brief alcohol intervention in a primary care setting for HIV-infected men who have sex with men. His most recent publications focus on (a) alcohol use and smoking cessation, (b) hostility, depressive symptoms, sensation seeking and smoking cessation outcome, (c) the application of item response theory to measures of alcohol problems, and (d) personality, psychopathology and smoking.

Institutions

Bh

Research Description

Christopher Kahler's work has focused on three primary topics: (a) the contribution of personality, psychiatric conditions, and emotional processes to the causes and treatment of alcohol and tobacco addiction, (b) methods for assessing alcohol use, problems, and dependence, and (c) the etiology and treatment of the co-use of alcohol and tobacco. He has published extensively in these and other areas with over 140 peer-reviewed publications to date. His most recent publications focus on changes in depressive symptoms following smoking cessation, the measurement of alcohol use and problems, relations between smoking, personality and psychopathology, and the treatment of heavy alcohol use in the context of smoking cessation treatment. He is currently conducting an NIAAA-funded laboratory study that investigates cognitive, affective, and behavioral mechanisms through which alcohol, when consumed in the lab, contributes to difficulties in delaying smoking when delaying smoking is rewarded with money. He is also conducting a randomized clinical trial comparing naltrexone to placebo among at-risk and problem drinkers seeking smoking cessation treatment. The study tests the hypotheses that naltrexone, when added to nicotine patch and a smoking cessation treatment that incorporates a brief alcohol intervention, will result in a lower percentage of heavy drinking days and a greater odds of smoking abstinence compared to placebo. He is conducting a developmental trial to test the efficacy of incorporating positive psychotherapy into smoking cessation treatment. Finally, he is Scientific Director of the Alcohol Research Center on HIV, in which he is conducting a randomized clinical trial to test the effects of brief alcohol intervention on drinking and HIV-related outcomes among MSM in an HIV primary care clinic.

Awards

Leon A. Greenberg Memorial Award: Center of Alcohol Studies, Rutgers University, 1998

Affiliations

American Psychological Association, 1993 - present
Association of Behavioral and Cognitive Therapies (formerly known as the Association for Advancement of Behavior Therapy), 1993 - present
Society for Research on Nicotine and Tobacco, 1999 – present
Research Society on Alcoholism, 2000-present

Funded Research

CURRENT GRANTS
1. Principal Investigator
"Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment"
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA017181); Period: 6/20/09-3/31/14
Total direct costs: $2,000,805; Total indirect costs: $1,172,355

2. Principal Investigator
"Mechanisms Linking Alcohol Use and Smoking Relapse Risk"
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA016978); Period: 4/1/08-3/31/12
Total direct costs: $1,221,901; Total indirect costs: $720,021

3. Scientific Director and Research Component PI
"Alcohol and HIV: Biobehavioral Interactions and Intervention"
PI, Research Component 2: "Brief Alcohol Intervention for HIV-Infected MSM in a Primary Care Setting"
Principal Investigator: Peter Monti
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: P01 (AA019072); Period: 9/30/10-8/31/15
Total direct costs: $6,087,800; Total indirect costs: $1,305,707

4. Principal Investigator
"Development of Positive Psychotherapy for Smoking Cessation"
Agency: National Cancer Institute
Type: R01 (CA156241); Period: 1/1/11-12/31/12
Total direct costs: $403,281; Total indirect costs: $244,435

5. Co-Investigator
"Motivation and Skills for THC/ETOH+ Teens in Jail"
Principal Investigator: Lynda Stein, Ph.D.
Agency: National Institute on Drug Abuse
Type: R01 (DA018851); Period: 9/25/04-8/31/11
Total costs: $3,401,064

6. Mentor
"Integrated Smoking Cessation and Mood Management for Cardiac Patients"
Principal Investigator: Andrew Busch, Ph.D.
Agency: National Heart Lung and Blood Institute
Type: K23 (HL107391); Period 4/15/2011- 3/31/2016
Direct costs: $640,824

7. Co-Investigator
"Stepped Care for Mandated College Students"
Principal Investigator: Brian Borsari, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA015518); Period: 6/1/05-5/31/11
Total direct costs: $1,025,000

8. Co-Investigator
"Adolescent Treatment and 12-Step Mutual Help Involvement"
Principal Investigator: John F. Kelly, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA015526); Period: 4/10/06-4/30/11
Total direct costs: $900,000

9. Co-Investigator
"Brief intervention to reduce drinking and intimate partner violence in women"
Principal Investigator: Gregory L. Stuart, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA016315); Period: 4/1/07-3/31/12
Total direct costs: $975,000

10. Co-Investigator
"Ecological Momentary Assessment of Adolescent Smoking Cessation"
Principal Investigator: Chad J. Gwaltney
Agency: National Institute on Drug Abuse
Type: R01 (DA021677); Period: 04/01/2007 - 03/31/12
Total direct costs: $1,125,000; Total indirect costs: $662,907

11. Co-Investigator
"Marijuana's Acute Effects on Risk Taking, Sexual/HIV Risk, and Impulsivity"
Principal Investigator: Jane Metrik
Agency: National Institute on Drug Abuse
Type: R01 (DA021403); Period: 06/01/2007 - 04/31/11
Total direct costs: $600,000; Total indirect costs: $353,750

12. Co-Investigator
"Development of Behavioral Couples Treatment for Smoking Cessation"
Principal Investigator: Heather LaChance
Agency: National Institute on Drug Abuse
Type: R01 (DA021265); Period: 8/15/07-5/31/11
Total direct costs: $600,000; Total indirect costs: $353,750

13. Co-Investigator
"Initiation and Progression through Early Drinking Milestones in Underage Drinkers"
Principal Investigator: Kristina Jackson
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA16838); Period: 9/1/08-8/31/13
Total costs: $3,675,000

14. Primary Mentor
"Affective and Genetic Correlates of Amphetamine Response"
Principal Investigator: Adam Leventhal
Agency: National Institute on Drug Abuse
Type: K08 (DA025041); Period: 8/1/09 - 7/31/14
Total costs: $789,918

15. Co-Investigator
"Mechanisms Linking Anhedonia and Tobacco Addiction"
Principal Investigator: Adam Leventhal
Agency: National Institute on Drug Abuse
Type: R01 (DA026831); Period: 8/15/09 - 5/31/12
Total costs: $1,217,709

16. Co-Investigator
"Genetic Variation and Marijuana's Pharmacologic and Cue-Elicited Effects"
Principal Investigator: Jane Metrik
Agency: National Institute on Drug Abuse
Type: R03 (DA027484); Period: 9/15/2009- 08/31/2011
Total direct costs: $300,000; Total indirect costs: $185,375

17. Co-Investigator
"Brief Alcohol Intervention for School-to-Work Transitions"
Principal Investigator: Suzanne Colby
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA016000); Period: 9/20/2009- 08/31/2011
Total direct costs: $710,797; Total indirect costs: $438,817

18. Co-Investigator
"New Approaches to Mediation Analysis using Causal Inference Methods"
Principal Investigator: Joseph Hogan
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (1RC1AA019186); Period: 9/30/2009- 08/31/2011
Total direct costs: $659,623; Total indirect costs: $281,145

19. Primary Mentor
"Contextual risk factors for substance use in adolescent Reservation-dwelling American Indians"
Principal Investigator: Nichea S. Spillane
Agency: National Institute on Drug Abuse
Type: K08 (DA029094-01); Period: 6/1/10 - 5/31/15
Total costs: $880,352

20. Co-Investigator
"Negative Affect, Urges and Distress Tolerance, Effects on Cognition in AUDs"
Principal Investigator: Travis Cook
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA018129); Period: 09/01/10-08/31/14
Total direct costs: $972,176; Total indirect costs: $571,129

21. Co-Investigator
"Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk"
Principal Investigator: Peter Monti
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: 2R01 AA009892; Period: 9/1/10-8/31/15
Total direct costs (year 1): $ $498,733; Total costs (year 1): $785,134

22. Co-Mentor
"Impact of Excessive Alcohol Use on HIV-associated Brain Dysfunction: A Diffusion and Functional MRI Study"
Principal Investigator: Wing Gongvatana
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: K99AA020235-01; Period: 3/1/11-2/28/16

COMPLETED GRANTS
1. Principal Investigator
"Improving Smoking Cessation Outcomes in Heavy Drinkers"
Agency: National Institute on Drug Abuse
Type: R01 (DA015534) Period: 8/15/03-4/30/08
Total direct costs: $1,111,032; Total indirect costs: $535,085

2. Principal Investigator
"Mechanisms Linking Hostility and Smoking"
Agency: National Institute on Drug Abuse
Type: R21 (DA019628) Period: 3/5/06-2/29/09
Total direct costs: $278,434; Total indirect costs: $157,618

3. Principal Investigator
Diversity Supplement for "Mechanisms Linking Alcohol Use and Smoking Relapse Risk"
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA016978-S1); Period: 7/25/08-12/31/10
Total direct costs: $141,322; Total indirect costs: $83,380

4. Co-Investigator
"Coping with Depression in Smoking Cessation"
Principal Investigator: Richard A. Brown, Ph.D.
Agency: National Institute on Drug Abuse
Type:R01 (DA08511); Period: 7/1/97 - 5/31/01
Total costs: $ 1,983,952

5. Co-Investigator
"Efficacy of Depression Skills Treatment with Alcoholics"
Principal Investigator: Richard A. Brown, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type:R01 (AA10958) Period: 7/1/97 – 6/30/01
Total costs: $1,886,845

6. Co-Investigator
"Nicotine Dependence: Risk and Recovery over Generations"
Principal Investigator: David B. Abrams, Ph.D.
Agency: National Cancer Institute
Type: P50 (CA84719); Period:10/1/99 – 9/30/04
Total costs: $11,582,454

7. Co-Investigator
"Biobehavioral Vulnerability to Early Smoking Relapse"
Principal Investigator: Richard A. Brown, Ph.D.
Agency: National Cancer Institute
Type: R23 (CA99014); Period: 9/1/00-8/31/02
Total costs: $362,500

8. Co-Investigator
"Applying Exercise Intervention to Drug Treatment"
Principal Investigator: Richard A. Brown, Ph.D.
Agency: National Institute on Drug Abuse
Type: RO1 (DA14599); Period 9/30/01 - 8/31/04
Total costs: $826,072

9. Co-Investigator
"Development of an Exercise Intervention for Alcoholics"
Principal Investigator: Richard A. Brown, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: RO1 (AA13418); Period 3/01/02 - 2/28/05
Total costs: $618,6960

10. Co-Investigator
"Preventing Depression in MMT Patients on Interferon"
Principal Investigator: Susan E. Ramsey, Ph.D.
Agency: National Institute on Drug Abuse
Type: R01 (DA016797); Period: 9/1/03 - 6/30/06
Total costs: $911,684

11. Co-Investigator
"Mechanisms Relating Conduct Disorder and Drug Abuse"
Principal Investigator: Robert Miranda, Ph.D.
Agency: National Institute on Drug Abuse
Type: R21 (DA016904); Period: 9/1/03-8/30/06
Total direct costs: $300,000

12. Co-Investigator
"Distress Tolerance Treatment for Early Smoking Lapsers"
Principal Investigator: Richard A. Brown, Ph.D.
Agency: National Institute on Drug Abuse
Type: R01 (DA017332); Period: 9/1/03-8/30/06
Total costs: $1,095,000

13. Co-Investigator
"Treatment of Youth Alcohol Abuse and Suicidality"
Principal Investigator: Christianne Esposito-Smythers, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA014191); Period: 4/15/04 - 10/31/07
Total direct costs: $750,000

14. Co-Investigator
"Effect of Mood on Impulsivity Among Adolescent Smokers"
Principal Investigator: Chad Gwaltney, Ph.D.
Agency: National Institute on Drug Abuse
Type: R21 (DA018942); Period: 10/1/04 - 9/30/06
Total direct costs: $275,000

15. Co-Investigator
"Brief Intervention to Reduce Drinking among Batterers"
Principal Investigator: Gregory L. Stuart, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA014193); Period: 7/1/03-6/30/08
Total direct costs: $1,250,000

16. Co-Investigator
"MI for Teen Substance Abuse with Psychiatric Comorbidity"
Principal Investigator: Richard A. Brown, Ph.D.
Agency: National Institute on Drug Abuse
Type: R01 (DA016738); Period: 9/30/04 – 03/31/09
Total costs: $2,514,565

17. Co-Investigator
"Brief Alcohol Intervention with Depressed Patients"
Principal Investigator: Susan E. Ramsey, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA013895); Period: 9/5/03-5/31/09
Total costs: $1,843,646

18. Co-Investigator
"Mood Management Phone Counseling in Smoking Cessation"
Principal Investigator: David R. Strong, Ph.D.
Agency: National Institute on Drug Abuse
Type: R01 (DA017947); Period: 5/20/05-4/30/09
Total direct costs: $750,000

19. Co-Investigator
"Smoking Versus Alternative Reinforcers in Adolescents"
Principal Investigator: Suzanne M. Colby, Ph.D.
Agency: National Institute on Drug Abuse
Type: R01 (DA016737); Period: 9/1/03-6/30/09
Total costs: $1,931,2580

20. Co-Investigator
"Naturalistic Influences on Alcohol Problems in College"
Principal Investigator: Nancy P. Barnett, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R01 (AA13970); Period: 9/1/03-8/30/10
Total costs: $3,044,348

21. Co-Investigator
"Nicotine Dependence: Phenotype, Endophenotype and Contexts"
Principal Investigator: Ray Niaura, Ph.D.
Agency: National Cancer Institute
Type: P5O (CA84719); Period: 9/30/04 – 7/31/10
Total costs: $8,626,255

22. Co-Investigator
"Underage Alcohol Use: Sequence and Progression of Early Drinking Milestones"
Principal Investigator: Kristina Jackson
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R21 (DA021403); Period: 07/10/2007 - 6/30/10
Total direct costs: $247,500; Total indirect costs: $391,667

23. Co-Investigator
"Alcohol Phenotype Development in American Samoa"
Principal Investigator: Robert Swift
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: R21 (AA016597); Period: 8/5/07-4/30/10
Total direct costs: $255,000

24. Co-Mentor
"Identifying Mechanisms of Motivational Interviewing"
Principal Investigator: Timothy Apodaca, Ph.D.
Agency: National Institute on Alcohol Abuse and Alcoholism
Type: K23 (AA15595); Period: 04/01/05-03/31/11
Total costs: $735,131

Teaching Experience

Applied Multiple Regression Analysis for Behavioral Sciences
Multilevel Modeling for Behavioral Sciences
Comorbidity of Alcohol and Smoking
Alcoholics Anonymous and Other 12-Step Programs

View My Full Publication List in pdf format

Selected Publications

• Kahler, C. W., Spillane, N. S., Busch, A. M., & Leventhal, A. M. (2011). Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment. Nicotine & Tobacco Research, 13, 146-150.(2011)
• Kahler, C.W., Leventhal, A.M., Daughters, S.B., Clark, M.A., Colby, S.M., Ramsey, S.E., Boergers, J., Abrams, D.B., Niaura, R., & Buka, S.L. (2010). Relationships of personality and psychiatric disorders to multiple domains of smoking motives and dependence in middle-aged adults. Nicotine & Tobacco Research, 12, 381-389.(2010)
• Kahler, C.W., Borland, R., Hyland, A., McKee, S.A., O'Connor, R.J., Fong, G.T., & Cummings, K.M. (2010). Quitting smoking and change in alcohol consumption in the International Tobacco Control (ITC) Four Country Survey. Drug and Alcohol Dependence, 110, 101-107.(2010)
• Kahler, C.W., Spillane, N.S., & Metrik, J. (2010). Alcohol use and initial smoking lapses among heavy drinkers in smoking cessation treatment. Nicotine & Tobacco Research, 12, 781-785.(2010)
• Kahler, C.W., Daughters, S.B., Leventhal, A.M., Rogers, M.L., Clark, M.A., Colby, S.M., Boergers, J., Ramsey, S.E., Abrams, D.B., Niaura, R., & Buka, S.L. (2009). Personality, psychiatric disorders, and smoking in middle-aged adults. Nicotine & Tobacco Research, 11, 833-841.(2009)
• Brown R.A., Lejuez, C.W., Strong, D.R., Kahler, C.W., Zvolensky, M.J., Carpenter, L.L., Niaura, R., & Price, L.H. (2009). A prospective examination of distress tolerance and early smoking lapse in adult self-quitters. Nicotine & Tobacco Research, 11, 493-502.(2009)
• Kahler, C.W., Spillane, N.S., Leventhal, A.M., Strong, D.R., Brown, R.A., and Monti, P.M. (2009). Hostility and smoking cessation treatment outcome in heavy social drinkers. Psychology of Addictive Behaviors, 23, 67-76.(2009)
• Kahler, C.W., Borland, R., Hyland, A., McKee, S.A., Thompson, M.E., & Cummings, K.M. (2009). Alcohol consumption and quitting smoking in the International Tobacco Control (ITC) Four Country Survey. Drug and Alcohol Dependence, 100, 214-220.(2009)
• Kahler, C.W., Hoeppner, B.B., & Jackson, K.M. (2009). A Rasch model analysis of alcohol consumption and problems across adolescence and young adulthood. Alcoholism: Clinical and Experimental Research, 33, 663-673.(2009)
• Kahler, C.W., Spillane, N.S., Metrik, J., Leventhal, A.M., & Monti, P.M. (2009). Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers. Pharmacology, Biochemistry and Behavior, 93, 285-290.(2009)
• Bornovalova, M. A., Gwadz, M., Kahler, C. W., Aklin, W. M., & Lejuez, C. W. (2008). Sensation seeking and risk-taking propensity as mediators in the relationship between childhood abuse and HIV-related risk behavior. Child Abuse and Neglect, 32, 99-109.(2008)
• Morgenstern, J., Blanchard, K.A., Kahler, C.W., Barbosa, K.M., McCrady, B.S., & McVeigh, K.H. (2008). Testing mechanisms of action for intensive case management. Addiction, 103, 469-477.(2008)
• Kahler, C.W., Strong, D.R., Papandonatos, G.D., Colby, S.M., Clark, M.A., Boergers, J., Niaura, R., Abrams, D.B., & Buka, S.L. (2008). Cigarette smoking and the lifetime alcohol involvement continuum. Drug and Alcohol Dependence, 93, 111-120.(2008)
• Kahler, C.W., Metrik, J., LaChance, H.R., Ramsey, S.E., Abrams, D.B., Monti, P.M.,& Brown, R.A. (2008). Addressing heavy drinking in smoking cessation treatment: A randomized clinical trial. Journal of Consulting and Clinical Psychology, 76, 852-862.(2008)
• Lejuez, C. W., Aklin, W. M., Daughters, S. B., Zvolensky, M. J., Kahler, C. W., & Gwadz, M. (2007). Reliability and validity of the youth version of the Balloon Analogue Risk Task (BART-Y) in the assessment of risk-taking behavior among inner-city adolescents. Journal of Clinical Child and Adolescent Psychology, 36, 106-111.(2007)
• Ray, L.A., Miranda, R., Kahler, C.W., Leventhal, A.M., Monti, P.M., Swift, R., & Hutchison, K.E. (2007). Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: A pilot study. Psychopharmacology, 193, 449-456.(2007)
• Kahler, C.W., LaChance, H.R., Strong, D.R., Ramsey, S.E., Monti, P.M., & Brown, R.A. (2007). The commitment to quitting smoking scale: Initial validation in a smoking cessation trial for heavy social drinkers. Addictive Behaviors, 32, 2420-2424.(2007)
• Strong, D.R., & Kahler, C.W. (2007). Evaluation of the continuum of gambling problems using the DSM-IV. Addiction, 102, 713-721.(2007)
• Morgenstern, J., Irwin. T, Wainberg, M., Parsons, J., Muench, F., Bux, D., Kahler, C.W., Marcus, S., & Schulz-Heik, J. (2007). A randomized controlled trial of goal choice interventions for alcohol use disorders among men-who-have-sex-with-men. Journal of Consulting and Clinical Psychology, 75, 72-84.(2007)
• Brown, R.A., Niaura, R., Lloyd-Richardson, E.E., Strong, D.R., Kahler, C.W., Abrantes, A.M., Abrams, D. & Miller, I.W. (2007). Bupropion and cognitive behavioral treatment for depression in smoking cessation. Nicotine & Tobacco Research, 9, 721-30.(2007)
• Kahler, C.W., Kelly, J.F., Strong, D.R., Stuart, G.L., & Brown, R.A. (2006). Development and initial validation of a 12-step participation expectancies questionnaire. Journal of Studies on Alcohol, 67, 538-542.(2006)
• Kahler, C.W., & Strong, D.R. (2006). A Rasch model analysis of DSM-IV alcohol abuse and dependence items in the National Epidemiological Survey on Alcohol and Related Conditions. Alcoholism: Clinical and Experimental Research, 30, 1165-1175.(2006)
• Kahler, C.W., Strong, D.R., & Read, J.P. (2005). Towards efficient and comprehensive measurement of the alcohol problems continuum in college students: The Brief Young Adult Alcohol Consequences Questionnaire. Alcoholism: Clinical and Experimental Research, 29, 1180-1189.(2005)
• Daughters, S.B., Lejuez, C.W., Bornovalova, M.A., Kahler, C.W., Strong, D., & Brown, R. (2005). Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. Journal of Abnormal Psychology, 114, 729-734.(2005)
• Kahler, C.W., Strong, D.R., Niaura, R., & Brown, R.A. (2004). Hostility in smokers with past major depressive disorder: Relation to smoking patterns, reasons for quitting, and cessation outcomes. Nicotine & Tobacco Research, 6, 809-818.(2004)
• Kahler, C. W., Strong, D. R., Read, J. P., Palfai, T. P., & Wood, M. D. (2004). Mapping the continuum of alcohol problems in college students: A Rasch model analysis. Psychology of Addictive Behaviors, 18, 322-333.(2004)
• McCrady, B.S., Epstein, E.E., & Kahler, C.W. (2004). AA and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18 month outcomes. Journal of Consulting and Clinical Psychology, 72, 870-878.(2004)
• Kahler, C. W., Read, J. P., Stuart, G. L., Ramsey, S. E., McCrady, B. S., & Brown, R. A. (2004). Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology, 72, 736-741.(2004)
• Rohde, P., Kahler, C. W., Lewinsohn, P. M., & Brown, R. A. (2004). Psychiatric disorders, familial factors, and cigarette smoking: III. Associations with cessation by young adulthood among daily smokers. Nicotine & Tobacco Research, 6, 509-522.(2004)
• Rohde, P., Kahler, C.W., Lewinsohn, P.M., & Brown, R.A. (2004).Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. Nicotine & Tobacco Research, 6, 119-132.(2004)
• Kalman, D., Kahler, C.W., Tirch, D., Kaschub, C., Penk, W., & Monti, P.M. (2004). Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychology of Addictive Behaviors, 18, 78-82.(2004)
• Kahler, C. W., Strong, D. R., Stuart, G.L., Moore, T.M., & Ramsey, S.E. (2003). Item functioning of the Alcohol Dependence Scale in a high-risk sample. Drug and Alcohol Dependence, 72, 183-192.(2003)
• Lejuez, C. W., Aklin, W. M., Jones, H. A., Richards, J. R., Strong, D. R., Kahler, C. W., & Read, J. P. (2003). The balloon analogue risk task (BART) differentiates smokers and nonsmokers. Experimental and Clinical Psychopharmacology, 11, 26-33.(2003)
• Kahler, C. W., Strong, D. R., Hayaki, J., Ramsey, S. E., & Brown, R. A. (2003). An item response analysis of the Alcohol Dependence Scale in treatment-seeking alcoholics. Journal of Studies on Alcohol, 64, 127-136.(2003)
• Brown, R.A., Ramsey, S.E., Strong, D.R., Myers, M.G., Kahler, C.W., Lejuez, C.W., Niaura, R., Pallonen, U.E., Kazura, A.N., Goldstein, M.G., & Abrams, D.B. (2003). Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tobacco Control, 12(Suppl), IV3-IV10.(2003)
• Kahler, C. W., Read, J. P., Wood, M. D., & Palfai, T. P. (2003). Social environmental selection as a mediator of gender, ethnic, and personality effects on college student drinking. Psychology of Addictive Behaviors, 17, 226-234.(2003)
• Rohde, P., Lewinsohn, P. M., Brown, R. A., Gau, J. M., & Kahler, C. W. (2003). Psychiatric disorders, familial factors, and cigarette smoking: 1. Associations with smoking initiation. Nicotine & Tobacco Research, 5, 85-98.(2003)
• Kahler, C.W., Brown, R.A., Ramsey, S. E., Niaura, R., Abrams, D. B., Goldstein, M. G., Mueller, T. I., & Miller, I. W. (2002). Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. Journal of Abnormal Psychology, 4, 670-675.(2002)
• Lejuez, C. W., Read, J. P., Kahler, C. W., Richards, J. B., Ramsey, S. E., Stuart, G. L., Strong, D. R., & Brown, R. A. (2002). Evaluation of a Behavioral Measure of Risk-Taking: The Balloon Analogue Risk Task (BART). Journal of Experimental Psychology: Applied, 8, 75-84.(2002)
• Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., Goldstein, M. G., Burgess, E. S., & Miller, I. W. (2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69, 471-480.(2001)